ACIP releases recommendations for use of live, attenuated influenza vaccine.
Ressel
Genevieve W
GW
D000293:Adolescent; D000328:Adult; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D007251:Influenza, Human / Q000517:prevention & control*; D008875:Middle Aged; D012307:Risk Factors; D014481:United States; D014611:Vaccination / Q000009:adverse effects / Q000592:standards*; D014613:Vaccines, Attenuated / Q000008:administration & dosage* / Q000009:adverse effects
D007252:Influenza Vaccines; D014613:Vaccines, Attenuated